Sanofi (SNY) Other Working Capital Changes (2009 - 2026)

Sanofi has disclosed Other Working Capital Changes across 16 years of filings, most recently posting -$387.6 million for Q4 2025.

• In Q4 2025, Other Working Capital Changes fell 28.63% year-over-year to -$387.6 million; the TTM figure through Dec 2025 stood at -$1.3 billion (down 20.86% YoY), while the FY2025 annual figure was -$387.6 million, down 27.0% from the prior year.
• Other Working Capital Changes came in at -$387.6 million for Q4 2025 at Sanofi, down from -$301.3 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $1.8 billion in Q2 2024 to a low of -$2.5 billion in Q3 2024.
• Average Other Working Capital Changes over 5 years is -$342.2 million, with a median of -$101.0 million recorded in 2025.
• The largest YoY upside for Other Working Capital Changes was 38.91% in 2021 against a maximum downside of 2303.86% in 2021.
• Over 5 years, Other Working Capital Changes stood at -$170.5 million in 2021, then plunged by 74.18% to -$296.9 million in 2022, then increased by 8.31% to -$272.2 million in 2023, then slipped by 10.7% to -$301.3 million in 2024, then retreated by 28.63% to -$387.6 million in 2025.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$387.6 million in Q4 2025, -$301.3 million in Q4 2024, and -$272.2 million in Q4 2023.